Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment for Dupuytren’s contracture. In ...

Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment of Dupuytren’s contracture as the ...

Q: Is surgery for Dupuytren’s contracture safe? What kind of results can I expect after surgery? Are there any alternatives to surgery? A: Surgery is the traditional treatment for Dupuytren’s ...

About Dupuytren's ContractureDC is a lifelong condition that may get worse over time. It's caused by a buildup of collagen in the hand, which forms a rope-like cord that pulls fingers toward the palm ...

NEW YORK (CBSNewYork) -- The hand condition dupuytren's disease affects millions of people, including CBS2's own Dr. Max Gomez. It causes a thickening and contraction of the sheet of connective tissue ...

With his pinkie finger stuck in a downward position, Tim Hickey had a few complaints. He couldn't lift barbells anymore. He had trouble operating a chain saw. But worst of all, he said his contracted ...

In a large, head-to-head trial pitting collagenase injections against limited fasciotomy as treatments for Dupuytren's contracture, the knife won. In the open-label trial, self-reported hand health ...

May 1, 2006 — Editor's Note: Dupuytren's contracture is a progressively debilitating hand disease that involves an abnormal thickening and contracture of tough tissue in the palm, causing the fingers ...

June 3, 2011 (London, United Kingdom) — Injectable collagenase significantly improved range of motion and degree of contracture in patients with Dupuytren's contracture, compared with placebo, in a ...

Injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules is effective in reducing nodule hardness and nodule size. Researchers at the Kennedy Institute, University of Oxford, led by ...

DUBLIN, Jan. 19, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that two new presentations related to Dupuytren's contracture and XIAFLEX ® (collagenase clostridium ...